Skip to content

Evaluation of the effect of extract of nettle (Urtica Dioica) on blood glucose in adolescent patients with type 1 diabetes , A Randomized Double Blinded Controlled Trial

Evaluation of the effect of extract of nettle (Urtica Dioica) on blood glucose in adolescent patients with type 1 diabetes , A Randomized Double Blinded Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220516054879N2
Enrollment
50
Registered
2022-07-06
Start date
2022-07-23
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes - insulin - children. Insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group received insulin with 5 cc of zardband company nettle syrup (Hydroalcoholic extract) twice a day for 12 weeks. Intervention 2: Control group received routine insuli

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 12-18 years old Patients with type 1 diabetes treated with insulin and with improper blood sugar control (A1C greater than 6.5 mg / dl) provided that their BUN and serum creatinine are satisfactory and the patient does not classified as a patient with renal impairment.(BUN 8-20 mg / dL and creatinine less than 1.5 mg / dL.)

Exclusion criteria

Exclusion criteria: Patient reluctance Patient taking lithium, warfarin and antihypertensive drugs Due to the existence of drug interactions according to the WHO source History of previous allergies to nettle edible products Change of more than 0.3 units in the parameters of patient's renal function

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose sugar reduction. Timepoint: The variable will be measured at the beginning of the study, 4, 8 and 12 weeks after the start of the study. Method of measurement: Home glucose testing devices or blood tests.

Secondary

MeasureTime frame
A1C reduction. Timepoint: This variable will be measured at the beginning of the study and 12 weeks after the start of the study. Method of measurement: blood test.;Insulin dose reduction. Timepoint: This variable will be measured at the beginning of the study and 12 weeks after the start of the study. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Shahrokhi

Rasht University of Medical Sciences

shahrokhi.mail85@gmail.com+98 13 3336 9019

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026